Clinical trial
Phase 4 Study of the Effect of Simvastatin Treatment on Inflammatory Response and Endothelial Function After Myocardial Infarction
NCT00906451 is registered in ClinicalTrials.gov with Brasilia Heart Study Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 4 Study of the Effect of Simvastatin Treatment on Inflammatory Response and Endothelial Function After Myocardial Infarction
- Lead sponsor
- Brasilia Heart Study Group
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2008
- Completion date
- May 31, 2009
- Enrollment
- 58 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
endothelial dysfunction, inflammation, myocardial infarction